Four short links: 26 March 2013

Patenting Preventing Placebos, Simulating Malaria, Pricing Experiments, and Mining Bitcoin

  1. Patent on Medical Trial Design to Reduce Placebo Effectdrug companies say these failures are happening not because their drugs are ineffective, but because placebos have recently become more effective in clinical trials. […] The whole idea that placebo effect is getting in the way of producing meaningful results is repugnant, I think, to anyone with scientific training. What’s even more repugnant, however, is that Fava’s group didn’t stop with a mere paper in Psychotherapy and Psychosomatics. They went on to apply for, and obtain, U.S. patents on SPCD. (via Ben Goldacre)
  2. OpenMalaria (Google Code) — an open source C++ program for simulating malaria epidemiology and the impacts on that epidemiology of interventions against malaria. It is based on microsimulations of Plasmodium falciparum malaria in humans, originally developed for simulating malaria vaccines. (via Victoria Stodden)
  3. Pricing Experiments You Might Not Know But Can Learn From — compendium of ideas and experiments for pricing.
  4. Retrominer — mining Bitcoins on a NES. I’m delighted by the conceit, and noticing that Bitcoin is now sufficiently part of the zeitgeist as to feature in playful hacks.
tags: , , , , , , , ,

Get the O’Reilly Data Newsletter

Stay informed. Receive weekly insight from industry insiders.

Get the O’Reilly Web Ops and Performance Newsletter

Weekly insight from industry insiders. Plus exclusive content and offers.

Get the O’Reilly Programming Newsletter

Weekly insight from industry insiders. Plus exclusive content and offers.

Get the O’Reilly Hardware Newsletter

Get weekly insight and knowledge on how to design, prototype, manufacture, and market great connected devices.

Get Four Short Links in Your Inbox

Sign up to receive Nat’s eclectic collection of curated links every weekday.

Get the O’Reilly Design Newsletter

Stay informed. Receive weekly insight from industry insiders.

Get the O’Reilly Web Platform Newsletter

Stay informed. Receive weekly insight from industry insiders—plus exclusive content and offers.